Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more
Market Cap & Net Worth: Sedana Medical AB (SEDANA)
Sedana Medical AB (ST:SEDANA) has a market capitalization of $82.26 Million (Skr922.84 Million) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #20820 globally and #228 in its home market, demonstrating a 3.22% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sedana Medical AB's stock price Skr9.29 by its total outstanding shares 99336960 (99.34 Million).
Sedana Medical AB Market Cap History: 2017 to 2026
Sedana Medical AB's market capitalization history from 2017 to 2026. Data shows growth from $84.12 Million to $82.26 Million (5.23% CAGR).
Sedana Medical AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sedana Medical AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.45x
Sedana Medical AB's market cap is 0.45 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $84.12 Million | $40.43 Million | -$3.88 Million | 2.08x | N/A |
| 2018 | $172.23 Million | $57.90 Million | -$6.87 Million | 2.97x | N/A |
| 2019 | $300.63 Million | $71.65 Million | -$16.36 Million | 4.20x | N/A |
| 2020 | $759.32 Million | $141.77 Million | -$27.14 Million | 5.36x | N/A |
| 2021 | $868.24 Million | $159.15 Million | -$57.97 Million | 5.46x | N/A |
| 2022 | $165.59 Million | $122.86 Million | -$73.51 Million | 1.35x | N/A |
| 2023 | $205.08 Million | $153.87 Million | -$59.61 Million | 1.33x | N/A |
| 2024 | $168.95 Million | $178.75 Million | -$10.67 Million | 0.95x | N/A |
| 2025 | $91.03 Million | $200.23 Million | -$59.24 Million | 0.45x | N/A |
Competitor Companies of SEDANA by Market Capitalization
Companies near Sedana Medical AB in the global market cap rankings as of March 18, 2026.
Key companies related to Sedana Medical AB by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Sedana Medical AB Historical Marketcap From 2017 to 2026
Between 2017 and today, Sedana Medical AB's market cap moved from $84.12 Million to $ 82.26 Million, with a yearly change of 5.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr82.26 Million | -9.63% |
| 2025 | Skr91.03 Million | -46.12% |
| 2024 | Skr168.95 Million | -17.62% |
| 2023 | Skr205.08 Million | +23.85% |
| 2022 | Skr165.59 Million | -80.93% |
| 2021 | Skr868.24 Million | +14.34% |
| 2020 | Skr759.32 Million | +152.58% |
| 2019 | Skr300.63 Million | +74.55% |
| 2018 | Skr172.23 Million | +104.74% |
| 2017 | Skr84.12 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Sedana Medical AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $82.26 Million USD |
| MoneyControl | $82.26 Million USD |
| MarketWatch | $82.26 Million USD |
| marketcap.company | $82.26 Million USD |
| Reuters | $82.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.